Genetic defects leading to hereditary thrombotic thrombocytopenic purpura

被引:64
作者
Kokame, K [1 ]
Miyata, T [1 ]
机构
[1] Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 5658565, Japan
关键词
D O I
10.1053/j.seminhematol.2003.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with thrombotic thrombocytopenic purpura (TTP), unusually large multimers of von Willebrand factor (VWF) circulate in the plasma. This is caused by a functional deficiency of VWF-cleaving protease, ADAMTS-13. Although TTP usually occurs as an acquired form due to autoantibodies against ADAMTS-13, the condition may be inherited in an autosomal recessive fashion. Thus far, genomic DNA from 23 patients with hereditary TTP and their families has been analyzed and 33 causative mutations identified in the ADAMTS13 gene: 19 missense, five nonsense, five frameshift, and four splice mutations. Common missense polymorphisms have been also found, one of which significantly reduces ADAMTS-13 activity. No cases have been found without mutations in the ADAMTS13 gene, suggesting that genetic defects in ADAMTS13 are the dominant cause of hereditary TTP. Further analysis may reveal the genetic background associated with acquired TTP and other thrombotic diseases. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 42 条
[1]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[2]   Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains [J].
Cal, S ;
Obaya, AJ ;
Llamazares, M ;
Garabaya, C ;
Quesada, V ;
López-Otín, C .
GENE, 2002, 283 (1-2) :49-62
[3]   Processing of von Willebrand factor by ADAMTS-13 [J].
Chung, DW ;
Fujikawa, K .
BIOCHEMISTRY, 2002, 41 (37) :11065-11070
[4]   IDENTIFICATION OF A CLEAVAGE SITE DIRECTING THE IMMUNOCHEMICAL DETECTION OF MOLECULAR ABNORMALITIES IN TYPE-IIA VONWILLEBRAND-FACTOR [J].
DENT, JA ;
BERKOWITZ, SD ;
WARE, J ;
KASPER, CK ;
RUGGERI, ZM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6306-6310
[5]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[6]   Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome [J].
Fujimura, Y ;
Matsumoto, M ;
Yagi, H ;
Yoshioka, A ;
Matsui, T ;
Titani, K .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) :25-34
[7]  
FUJIMURA Y, 1994, HAEMOSTASIS THROMBOS, P379
[8]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[9]   von Willebrand factor: molecular size and functional activity [J].
Furlan, M .
ANNALS OF HEMATOLOGY, 1996, 72 (06) :341-348
[10]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234